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邦文要約
過剰なフルクトース負荷は2型糖尿病を発症さ
せることが報告されている。本研究では、わさ
びの水抽出エキスがフルクトース負荷ラットで
みられるインスリン抵抗性を軽減するか否かに
ついて検討した。 Wistarラットを、 1)15%フ
ルクトース溶液群、 2)15%のフルクトース溶
液及び 10%わさぴ水抽出物群、または 3)水
投与群の3群に分け、 6週間経過観察した。実
験最終に24時間尿を採取し、麻酔下に血液及び
臓器を摘出し以後の実験に用いた。 3群間で体
重及ぴ収縮期血圧に変化はみられなかったが、
フルクトース負荷群では大動脈壁の重批が増加
し、これはわさび投与群で有意に軽減した。フ
ルクトース負荷では、血糖及び血漿インスリン
浪度が有意に増加し、インスリン抵抗性の指標
である HOMA-R値は水投与群に比して有意に
高値であった。血糖及びインスリン浪度の上昇
はわさび群では有意に軽減し、水投与群との間
に差がみられなかった。フルクトース負荷によ
るインスリン感受性の低下は、糸球体濾過屈の
増加を伴っており、尿拭、尿中ナトリウム排泄
抵及び尿中タンパク排泄抵が有意に高値を示し
た。わさび抽出物の投与により、尿批、尿中ナ
トリウム排泄拭及びタンパク排泄批は低下し、
水投与群との間で差はみられなかった。高速液
体クロマトグラフィー分析により、わさび抽出
物には強力な酸素ラジカル・スカベンジャー
である 6 メチルスルフィニルヘキシルイソ
チオシアン酸 (6MSITC)が含有されること
が示されたが、わさび抽出物中の6MSITC祉
はインスリン感受性の改善に必要とされる最よ
り低いことが明らかとなったことから、わさび
抽出物中のインスリン抵抗性の改善には、 6
MSITC以外の物質の関与も示唆された。
ABSTRACT 
Fructose loading results in the development of 
type-2 diabetes. In the present study we ex-
amined whether W asabi extract attenuates 
insulin resistance in fructose-loaded Wistar rats. 
The rats were randomly assigned to one of the 
following groups: 1) rats given 15% fructose 
solution. 2) rats given 15% fructose and 10% 
Wasabi extracts, and 3) rats given water. They 
were maintained for 6 weeks. There were no 
differences in body weight or systolic blood 
pressure among the three experimental groups. 
Weights of aortic walls increased with fructose 
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loading and this was abolished witl1 W asabi 
extracts u-ea血 ems.Fructose loading signifi-
cantly increased plasma insulin concentrations 
in association with increased plasma glucose 
levels. thereby increasing levels of HOMA-R. 
an indicator of insulin resistance. These alter-
ations were reversed with Wasabi extract to 
normal levels as in control rats. Decreased 
insulin sensitivity was associated with glo-
merular hyperfilti・ation皿 dincreases in urine 
volume. and urinary sodium and protein ex-
cretion. These altered urinary parameters in 
fructose loading were significantly attenuated 
witl1肛ea血 entwith Wasabi extracts. Wasabi 
extracts contain a potent oxygen radical 
scavenger. 6-me由ylsulfinylhexyl isothiocya-
nate (6-MSITC) as assessed by C1s reversed 
phase HPLC; however. the amount of 6-MSITC 
present was much lower than the amount 
required to restore insulin sensitivity. These 
results suggest tl1at Wasabi extracts attenuate 
insulin resistance induced by fructose loading, 
and this is associated with decreased glomer-
ular hyperfiltration and urinary protein excre-
tion. These benefits may be attributed to sub-
stances other than 6-MSITC in Wasabi ex-
tJ・acts. 
INTRODUCTION 
According to National Health and Nutrition 
Surveillance in Japan. the prevalence of dia-
betes has increased over the past 2 decadesり
More than 90% of the patients have type-2 
diabetes. whereas Caucasian people in tl1e US 
and Europe commonly suffer from type-1 dia-
betes. The reason for this difference is not 
clear: however. it may be due to differences in 
genetic background. life style. or food culture. 
Recent studies suggested that excessive fruc-
tose-intake causes type-2 diabetes in rodents 2l-5>_ 
However. it is not clear whether this also oc-
curs in humans. In general. elderly people in 
Japan consume more tl1an 150g of sweet fruits 
per day亙Thatcorresponds to an intake of 
more tl1an 22g sucrose per day if the fruits 
contain brix 15% fructose. Such a high intake 
for a long time potentialy becomes a risk for 
type-2 diabetes. Diabetes is a main cause of 
renal impairment and subsequent hemodialysis 
or kidney transplant. Glycosylation or hyper-
secretion of insulin. and proteinuria al play a 
critical role in renal impairment that occurs 
with diabetes. 
On由eother hand, W asabi is a member of the 
Brassicaceae group along with Armoracia 
rusticana. known as horseradish in western 
countries. Wasabi is essentially Japanese 
horseradish, and bears a resemblance to 
horseradish in western coun肛ies (Fig. 1). 
Wasabi was first described as food in the 
Asuka era of Japan, 592-710 AD 7>_ Since then, it 
has been an integral cuisine in Japanese food 
culture. It is often used as a spice in Sushi or 
Sashimi witl1 raw fish. However. it isnot clear 
whether Wasabi is useful to promote health. 
Figure l 
a) b) 
Figure l.Appearance of horse radish and ¥Vasab1 
Left panel represents horse radish (Armorac店rusa"cana)
and山eright panel depicts Japanese horse radish. Wasabi 
(W asabi or Eutrema). The rot indicated was used for this 
experiment. 
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Recently, however, it was reported that Wasabi 
contains potent oxygen radical scavenger, 
6-methylsulfinyl hexyl isothiocyanate (6-MSITC). 
and works as a bactericidal substance 8>_ 
Moreover. hot water extract from W asabi 
attenuates body weight gain by suppressing 
PP AR-y and decreasing body fat of mice 91. To 
this context Fukuchi et al. reported that oral 
administration of 6-MSITC ameliorates diabetic 
nephropathy in type 2 diabetic mice四
Considering these results. present study in-
vestigated the influence of long-term W asabi 
intake on the early stage of type-2 diabetes 
induced with fructose loading in Wistar rats, 
especially with regard to insulin resistance and 
glomerular hyperfiltration. 
MATERIALS and METHODS 
1) Design 
Wistar male rats aged 5 weeks were purchased 
from Sankyo Laboratory, Tokyo, Japan. The 
rats were fed regular chow (0.75%NaCI. w /w) 
(Oriental Kobo Co . Ltd., Tokyo, Japan). At the 
age of 7 weeks, the rats were randomly as-
signed to 1) control group given water. 2) 
fructose group given 15% (w /v) fructose solu-
tion (W ako Pure Chemicals, Tokyo, Japan) or 3) 
Wasabi group given 15% (w /v) fructose and 
10% (w /v) Wasabi solutions (Marutoh Co . 
Shizuoka Japan). 
W asabi root was homogenized in water by 
Polytron blender (KINEMA TIKA, Luzern. 
Switzerland) and the homogenates were fil-
tered through a cotton filter. The water-soluble 
extract was given to the rats as Wasabi solu-
tion. The regular chow used in the present 
study was made according to the recommen-
dation for animal research reported by Amer-
ican Institute of Nutrition (AIN-76 and AIN-93). 
Each solution and the chow were available ad 
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libitum. 
At the end of study, the rats were placed in a 
metabolic cage to obtain urine for 24-h u,i互
After 12-h of fasting, the rats were anesthe-
tized with pentobarbital (75mg/kg body 
weight) and then blood samples and organs of 
interest were obtained. The samples were 
stored at -80DC until use. 
2) Determinations of parameters 
Systolic blcxi pressure was determined by the 
tail-cuf me血d(Natsume Manometer-Tachometer 
model KN-210-1. Tokyo, Japan) 13. Protein ex-
cretion in urine was determined using Protein 
assay kit BioRad, Tokyo, Japan. Electrolytes in 
blood and urine were determined using an 
autoanalyzer. 
3) C1s reversed phase high performance 
chromatography (C1s-HPLC) 
Ten percent Wasabi extract was analyzed 
using CぽHPLCsystem equipped with Crest 
Pak Cl8S column, PU-4180 pump and UV de-
tector UV-4075 controlled by LC-Netll/ ADC 
GASCO Co . Ltd., Tokyo, Japan). Ten microliter 
of the extract was applied onto C1s-HPLC 
prewashed with 0.1 % formic acid. The moving 
solvent system was 0.1 % formic acid with a 
0-70% methanol gradient for 20 min. Flow rate 
was lmL/min. For comparison. we analyzed 
C,s-HPLC pattern of 6-MSITC (Cayman 
Chemical. Ann Arbor, USA). 
4) Statistical analysis 
All statistical analyses were performed using 
ST A TISTICA software (StatSoft. Tulsa OK). 
Values were expressed as means±SD. Difer・ 
ences were assessed by one-way or two way 
factorial analysis of variance followed by 
post-hoc least significant difference (LSD) test 
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or Mann-Whitney U test P-values less than 0.05 
were considered statistically significant 
5) Guidelines for handling rats for experi— 
ments 
We followed the guidelines for experimental 
animal handling, and our study was approved 
by the Animal Care Committee of the Kyoritsu 
Women's University (#15001). The experiment 
was conducted in accordance with the National 
Institutes of Health (NIH) guidelines. 
RESULTS 
1) Effects of Wasabi on insulin sensitivity 
The rats gained bod weight in a 
time-dependent manner during the experi-
mental period. However, there were no dif-
ferences in body weight among the three ex-
perimental groups (Fig. 2). 
The rats given 15% fructose solution had 59% 
higher fasting plasma glucose concentrations 
F如re2
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Figure 2 Effects of W asabi on rat body weight upon fruc-
tose loading 
Open circle. fructose group (fructoset. closed circle. W asabi 
group (wasabit. open square, control (saline) group (controli 
The values are expressed as means土 SD.The differences 
were assessed by two-way ANOV A Rat body weight was 
significantly increased in a tim辺ependentmanner in the 
three experimental groups: however. difference among 
groups was not significant 
than control rats (Fig. 3-a). These higher 
plasma glucose concentrations were associated 
with significantly increased fasting plasma 
insulin concentrations compared with those in 
control rats (Fig. 3-b). Accordingly, the home-
ostasis model assessment insulin resistance 
(HOMA-R). a parameter of insulin resistance, 
was higher in the fructose group than in the 
control group, suggesting that insulin sensitiv-
ity was significantly decreased upon fructose 
loading (Fig. 3-c) 14し
In contrast, in the W asabi group, the increased 
fasting plasma glucose concentrations caused 
by fructose-loading declined in association with 
an attenuation of increased plasma insulin 
Figure 3 a) -
l1:  
b) • 
lI:  ・ 
・, 一一c) 
•—-一I • .,i — 
Figure 3. Effects of W asabi on glucose metabolism upon 
fructose loading in rats 
Fasting glucose concentration (a). plasma insulin concen-
trations (b). and HOMA-R (c) are shown control control 
(saline) group: fructose, fructose group and -;wasabl Wasabi 
group. The values are expressed as means土 SD.Differ。
ences were邸sessedby one-way ANOVA "p<0.05 vs 
control (saline) group. Ns represents statistically not signif-
icant 
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concentrations toward the control levels (Fig. 
3-a,b). Thus. HOMA-R in the Wasabi group was 
almost equal to that in the control group, 
suggesting improvement of insulin sensitivity 
upon W asabi consumption (Fig. 3-c). 
2) Hemodynamic changes 
At the end of the experiment, systolic blood 
pressures were 139±7 mmHg for control group, 
143±9 mmHg for fructose group, and 144土4
mmHg for W asabi group; there were no sig-
nificant differences among the three groups. 
Moreover. the changes in systolic blood pres-
sure during the study did not differ among the 
groups (Fig. 4). 
The organ weights are shown in Table 1. 
Weights of aortic walls were significantly in-
creased with in the fructose-loading group 
compared with weights in the control group. 
and this increase was almost completely abol-
ished in W asabi group. However. weights of the 
heart and kidney did not differ among the three 
experimental groups. The weights of the aortic 
walls were positively correlated with plasma 
insulin concentrations (r=0.465, p<0.05). 
3) Renal function 
Plasma creatinine concentrations were signif 
icantly increased in the fructose group; how-
Fi1Uro4 
???? ?
．， 
E —Palodo-t;I 
Figure 4. Effects of Wasabi on systolic blood pressure upon 
fructose loading in rats 
Open circle. fructose group (fructose): closed circle. Wasabi 
group (wasabi): open square. control (saline) group. The 
values are expressed as means土 SD.The differences were 
assessed by two-way ANOV A. 
ever. creatinine clearance rate (Ccr) was sig-
nificantly increased with in fructose-loading 
rats compared with Ccr in the control group, 
suggesting that hyperfiltration was occurring 
in the fructose group (Fig 5-a). Wasabi treat-
ment attenuated this hyperfiltration. and thee 
was no difference in Ccr between W asabi and 
control groups. 
Similarly, urine volume. urinary sodium excre-
tions and sodium clearance rate were signifi-
cantly increased with fructose-loading whereas 
fractional excretions of sodium (FENa) did not 
differ between fructose and control groups 
Table I. Organ weight of the experimental group 
Wasabi 0.162土0.014#
1.146土0.086
1.200土0.072
The values are expressed as means土SD.The differences were assessed by one-way ANOV A. ••p<0.01 vs 
_control group; #p<0.05 vs fructose group 
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Figure 5 
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(Table 2). In the W asabi group, urine volume. 
urinary sodium excretions and sodium clear-
ance rate were al decreased to the control 
levels. FENa did not differ between the fruc-
tose and W asabi groups. 
We examined urinary protein excretions (Fig. 
5-b). Fructose loading significantly increased 
urinary protein excretions compared with 
excretion levels in control rats, and this in-
crease was significantly attenuated in the 
W asabi group. 
We demonstrate the C1s-HPLC pattern of the 
Wasabi extract (10μL of 10% extract) in Fig-
ure 6. More than 31 peaks were detected. and 
one of them corresponded to the retention time 
(18.89 min) of the standard 6-MSITC as indi-
cated by an arrow in the figure. 
Figure 5. Efects of W asabi on creatinine clearance rate and 
urinary protein excretions 
Creatinine clearance rate (a) and urinary excretions of 
protein (b) are shown. control control (saline) group; fruc-
tose. fructose group and ;wasabi. Wasabi group. The values 
are expressed as means土 SD.The diference was assessed 
by one-way ANOV A 0p<0.05 vs control (saline) group. Ns 
represents statisticaly not significant 
DISCUSSION 
The most important fmding in this study was 
that fructose-loading increases insulin re-
sistance in Wistar rats. and this was attenuated 
by the intake of W asabi extracts. The decrease 
Table 2. Plasma and urinary electrolytes concentrations 
I variables control frucLosc Wasabi I 
Plasma 
pNa (mEq/L) 14.6土2.3 142.7土o.s・ 143.4土0.7
pK (mEq/L) 4.32土0.19 4.06土0.19・ 3.94 土 0.2300•
pCr (mg/dL) 0.37土0.01 0.42土0.03. 0.39土0.03
Urine 
UV (mL/lOOgBW /day) 1.04土0.50 16.26士8.03. 10.04土1.3
UNaV (mEq/lOOgBW/day) 0.12土0.07 0.29土0.130 0.14土0.091
CNa (mL/lOOgBW /day) 0.45土027 1.1士0.53"' 0.52士0.31
FENa (%) 0.19土0.13 0.26士0.1 0.15士0.1
UKV (mEq/lOOgBW /day) 0.40土0.25 0.34士0.12 0.38士0.14
CK (mL/lOOgBW /day) 1.52土0.97 1.29士0.48 1.39土0.49
UNa/K 0.73士0.47 0.87土0.37 0.51土0.3
pNa plasma sodium concentrations; pK. plasma potassium concentrations: pCr, plasma creatinine concentrations; 
UV. urine volume: UNaV. urinary sodium excretions: CNa sodium clearance rate; FENa fractional excretion of 
sodium: UKV警urinarypotassium excretions: CK. potassium clearance rate: UNa/K. ration of urinary sodium to 
potassium. The values are expressed as means土SD.The diferences were BS! 交s.sedby one-way ANOV A. "p<0.05. 
"p<0.01. . p<0.005 vs control group. #p<0.05 vs fructose group. 
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Figure 6 
UlA .... U1"•U•=J1Ut&, .. IU ... ・-
Figure 6. C1s reversed-phase HPLC analysis of Wasabi 
extract 
W asabi extract was analyzed as detailed in the text by 
high-performance liquid chromatography (HPLC). Ten 
microliter of lmg/mL standard 6-MSITC is indicated by an 
arrow. 
in insulin sensitivity in fructose-loaded rats was 
associated with glomerular hyperfiltration and 
proteinuria. The intake of Wasabi extracts 
reversed the glomerular hyperfiltration toward 
normal levels and attenuated proteinuria Thus. 
the data clearly suggest that the intake of 
W asabi extracts attenuates insulin resistance 
and glomerular hyperfiltration induced by 
fructose loading. 
Hyperfiltration in insulin resistance is mediated 
by increased permeability of the glomerular 
basement membranes or elevation of glomer-
ular blood pressure due to inappropriate insulin 
secretion 15H71_ Increased glomerular blood 
pressure causes albuminuria and massive 
proteinuria, and the leak of blood protein has a 
critical role in tubular and glomerular im-
pairment in diabetes. In this sense. it is im-
portant to normalize hyperfiltration along with 
restoring insulin sensitivity, as we demon-
strated with Wasabi extract. This suggests 
that Wasabi extract is useful to prevent prer 
gression from insulin resistance to overt type-2 
diabetes. 
Urinary sodium excretion was increased with 
fructose loading. Since FEN a was not changed 
upon fructose loading. the increased glomerular 
filtration may be related to the increase in 
urinary sodium excretion. W asabi consumption 
decreased the sodium excretion toward control 
levels, which supports that W asabi reverses 
hyperfiltration to normal levels. 
Interestingly, we demonstrated that weights of 
aortic walls were significantly increased with 
fructose loading compared with weights of 
control groups. This was significantly attenu-
ated upon feeding with Wasabi extract It is 
reported that high insulin secretion causes 
vascular hypertrophy through enhancing vas-
cular smooth muscle proliferation. In fact, we 
demonstrated that the weights of aortic walls 
positively correlated to plasma insulin concen-
trations. 
The attenuation of aortic hypertrophy by 
W asabi may be explained by the presence of 
6-MSITC, a potent antioxidant substance 18>-勾
According to HPLC analysis. W asabi extracts 
contained 0.25mg/mL 6-MSITC in this ex-
periment, resulting in approximately 
12.5mg/ day per rat (Fig. 6). This is far below 
the dose required to decrease blood glucose 
levels in genetic NIDDM mice w,_ Antioxidants 
enhance nitric oxide generation through eNOS 
activation, and thereby decrease systemic 
blood pressure. If 6-MSITC is involved in the 
increased insulin sensitivity observed in the 
W asabi group, systolic blood pressure would 
have declined. Considering these results, the 
restoration of insulin sensitivity by Wasabi 
extracts may not be mediated by 6-MSITC and 
reduction of oxidative stress. The exact 
mechanism remains to be elucidated. 
In conclusion, we demonstrated in the present 
study that consuming of Wasabi extracts at-
69 -
共立女子大学家政学部紀要 第64号 (2018)
tenuate insulin resistance in fructose-fed rats 
with decreases in urinary protein excretions 
and aortic wall weights. These may be related 
to decreases in plasma insulin levels. Sub-
stances responsible for such benefits remain to 
be elucidated; however, such benefits may be 
reflected by the fact that W asabi has been used 
as assortment for a long time in Japanese food 
culture. 
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